Enteral Feeding Devices Market: Growth Trends, Drivers, and Regional Outlook
The global enteral feeding devices market is witnessing steady expansion as healthcare systems worldwide grapple with a rising burden of chronic illnesses and an aging population that increasingly requires nutritional support. The market was valued at USD 2.47 billion in 2025 and is projected to grow from USD 2.54 billion in 2026 to USD 3.58 billion by 2034, registering a CAGR of 4.4% during the forecast period, according to Fortune Business Insight. North America led the industry in 2025, commanding a market share of 43.72%, according to Fortune Business Insight.
Understanding Enteral Feeding Devices
Enteral feeding devices are specialized medical instruments designed to deliver liquid nutrition directly into the gastrointestinal tract of patients who are unable to consume adequate calories orally. These devices include enteral feeding tubes—such as nasogastric tubes, gastrostomy tubes, and jejunostomy tubes—enteral feeding pumps, and various accessories that support safe and effective nutrient delivery. They play a critical role in managing patients suffering from neurological disorders, cancer, gastrointestinal diseases, and other conditions that compromise normal eating ability.
Key Market Drivers
The rising prevalence of chronic conditions is one of the foremost factors propelling demand for enteral feeding devices. As the number of patients requiring nutritional support through healthcare settings grows, so does the adoption of advanced feeding technologies. For instance, according to Fortune Business Insight, 2023 data published by the Cleveland Clinic indicated that an estimated 10,000 to 20,000 people in the U.S. are affected by short bowel syndrome, a condition that often necessitates enteral nutrition support.
The expanding geriatric population further compounds this trend, as older adults are more susceptible to conditions requiring tube feeding. Data published by the Alzheimer’s Association in 2023 revealed that more than 6 million Americans are living with Alzheimer’s disease, according to Fortune Business Insight, many of whom may eventually require nutritional assistance through enteral devices as the disease progresses.
Technological advancements have also played a pivotal role in shaping market growth. Improvements in tube materials, the rollout of ISO 80369-3 (ENFit) standards for safer connections, and the development of smart pumps with real-time monitoring capabilities have enhanced device functionality and patient safety. Companies such as Abbott, Fresenius Kabi, and Cardinal Health continue to invest heavily in research and development to introduce innovative products, reinforcing the market’s upward trajectory.
Shifting Preference Toward Homecare Settings
One of the most notable trends shaping the enteral feeding devices market is the growing shift toward home-based enteral nutrition (HEN). This transition is driven by the rising prevalence of chronic conditions requiring long-term nutritional support, the development of portable devices, and the benefits associated with home care, including shorter hospital stays, reduced infection risk, and fewer tube-related complications. According to Fortune Business Insight, data published by the National Home Infusion Association (NHIA) in 2024 showed that approximately 234,070 patients utilized home enteral nutrition that year.
Key players are responding to this shift by designing simplified administration sets and user-friendly pumps optimized for use outside clinical settings, further accelerating adoption among homecare patients.
Market Restraints and Challenges
Despite favorable growth prospects, the market faces certain headwinds. The high cost of advanced enteral feeding devices remains a significant barrier, particularly in developing economies such as India and South Africa. According to Fortune Business Insight, 2025 data published by Curemed indicated that feeding pump prices range from USD 720.0 to USD 1,800.0, a cost burden that is compounded by recurring expenses for administration sets, nutrition formulas, and feeding tubes.
Reimbursement limitations present another challenge. Coverage frameworks for enteral nutrition vary considerably across countries, with many developed and developing nations offering only partial reimbursement. According to Fortune Business Insight, 2023 data from the Centers for Medicare & Medicaid Services (CMS) noted that while enteral nutrition products qualify under the Prosthetic Device benefit, coverage excludes associated equipment, supplies, and orally administered enteral nutrition products. Additionally, placement complications such as aspiration risk and tube dislodgement, along with training gaps among caregivers in home settings, continue to pose operational challenges for the industry.
Segmental Insights
By product, the market is divided into instruments and accessories, with instruments—including feeding tubes and pumps—holding the largest share in 2025 due to rising chronic disease prevalence and continuous product innovation, according to Fortune Business Insight. The accessories segment is projected to grow at a CAGR of 4.5% through the forecast period.
By age group, adults dominated the market in 2025 and are expected to retain an 87.9% share in 2026, driven by the high prevalence of neurological disorders, cancer, and gastrointestinal conditions among adults, according to Fortune Business Insight. However, the pediatrics segment is anticipated to grow faster, at a CAGR of 5.3% through 2034.
In terms of application, oncology led the market with a 29.9% share in 2025, supported by the rising global cancer burden, according to Fortune Business Insight. The neurological disorders segment is expected to post the fastest growth, with a CAGR of 5.0% over the study period. By end user, hospitals and ambulatory surgical centers (ASCs) dominated with an anticipated 49.5% share in 2026, while homecare settings are projected to expand at a CAGR of 4.7%, according to Fortune Business Insight.
Regional Outlook
North America remains the dominant regional market, valued at USD 1.05 billion in 2024 and USD 1.08 billion in 2025, supported by robust healthcare infrastructure and favorable reimbursement policies, according to Fortune Business Insight. The U.S. market alone is estimated to reach USD 0.96 billion in 2026.
Europe is projected to reach USD 0.82 billion in 2026, propelled by growing ENFit adoption and expanding home-based enteral care, with the U.K., Germany, and France expected to contribute significant shares, according to Fortune Business Insight. Asia Pacific, the third-largest regional market, is estimated to reach USD 0.42 billion in 2026, with China and India emerging as key growth contributors.
Competitive Landscape
The market features prominent players such as Abbott, Fresenius Kabi, Cardinal Health, B. Braun SE, BD, Boston Scientific Corporation, and CONMED Corporation, among others. Recent developments include Cardinal Health’s launch of the Kangaroo OMNI Enteral Feeding Pump and Fresenius Kabi’s establishment of a new Enteral Nutrition Research and Development center in India in June 2025, according to Fortune Business Insight, reflecting the industry’s continued focus on innovation and geographic expansion.
Conclusion
The enteral feeding devices market is poised for steady growth through 2034, fueled by rising chronic disease prevalence, an aging population, and a growing preference for homecare-based nutritional support. While cost constraints and reimbursement challenges persist, ongoing technological innovation and expanding healthcare access worldwide are expected to sustain long-term demand for these essential medical devices.
What’s Driving Japan’s Market? Discover the Latest “Enteral Feeding Devices Market” Insights
https://www.fortunebusinessinsights.com/jp/%E7%B5%8C%E8%85%B8%E7%B5%A6%E9%A4%8C%E8%A3%85%E7%BD%AE%E5%B8%82%E5%A0%B4-112053